Inadequate sensitivity and specificity of currently-used imaging methods for cancer screening of the breast motivates the development of new modalities capable of adding diagnostic information. EMAI (electromagnetic acoustic imaging) is a novel imaging method which exploits tissue electrical conductivity and acoustic properties for the purposes of cancer detection. The technique relies on inducing ultrasound by electromagnetic irradiation of the tissue of interest in the radiofrequency (RF) range. This modality has advantages in the use of RF for illumination which has been well-developed in MRI, and the use of ultrasound receiving, thereby allowing for automatic image co-registration. Preliminary studies in phantoms have confirmed theoretical predictions in that the induced ultrasound signal occurs at two frequencies (the incident and twice that) and depends on conductivity gradients. In this fast-track STTR application, work is proposed to demonstrate the feasibility of EMAI as a potentially clinically useful cancer screening imaging method.
The specific aims of Phase I are: 1) design and characterize conductivity phantoms, 2) build and test imager components, 3) optimize RF pulse sequence, and 4) extend previously obtained experimental verifications of EMAI theory. The quantitative milestones obtained during Phase I will be 1) induced ultrasound SNR as a function of conductivity gradient in phantoms at specified source-receiver distances, 2) EMAI SNR as a function of volume of region of interest with homogeneous conductivity, 3) EMAI SNR at the RF frequency and at twice that frequency, 4) The time for signal averaging required to bring the overall SNR above 1, and 5) The temperature change in the phantom as a result of the RF power deposition. Phase II will focus on constructing a dual mode EMAI/US prototype imager with demonstration in small animals to show viability for future clinical use. Long-terms goals are to develop EMAI as a useful imaging technique for cancer screening, diagnosis, and monitoring.

Public Health Relevance

. The proposed project is designed to determine the feasibility of electromagnetic acoustic imaging (EMAI) for medical applications. EMAI produces conductivity-weighted ultrasound which will potentially improve diagnostic performance in cancer screening, and may be especially useful for screening and diagnosing breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
5R42CA133986-03
Application #
7936236
Study Section
Special Emphasis Panel (ZRG1-SBIB-U (92))
Program Officer
Beylin, David M
Project Start
2008-09-29
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
3
Fiscal Year
2010
Total Cost
$292,956
Indirect Cost
Name
Magnetus, LLC
Department
Type
DUNS #
098605020
City
Irvine
State
CA
Country
United States
Zip Code
92603
Emerson, Jane F; Chang, David B; McNaughton, Stuart et al. (2013) Electromagnetic acoustic imaging. IEEE Trans Ultrason Ferroelectr Freq Control 60:364-72